Ani Pharmaceuticals Inc (ANIP)
R&D Expense Growth
39.12%
Quarterly · Period ending:
ANIP R&D Expense Growth
Latest reported39.12%period ending
Latest reported39.12%period ending
ANIP Quarterly R&D Growth (QoQ) (0.00% → 39.12%)
Latest values, visible window
High-resolution chart · PNG
ANIP r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 66.2036% | |
| -20.5006% | |
| 22.3429% | |
| -79.421% | |
| 508.8866% | |
| 0% | |
| 0% |